Skip to main content

Table 1 Demographics and clinic manifestation of the research population. N = 891

From: The change in pediatric subject symptoms during the COVID-19 pandemic in China: an increase in cardiac consultation

Characteristic

Pre-COVID-19

COVID-19

Post-COVID-19

P value

Age, years

7.31 (0.40–15.70)

7.71 (0.020–14.89)

7.85 (0.278–17.32)

0.72

Men, n (%)

68 (55.29)

69 (53.08)

377 (59.01)

0.37

Median visit timea, days

7 (3–30)

10 (3–30)

3 (1–15)

<  0.01

Cardiac symptoms, n (%)

    

 Chest pain

44 (35.77)

42 (32.30)

280 (43.89)

0.03

 Chest tightness

61 (49.60)

75 (57.69)

313 (49.06)

 Palpitation

14 (11.38)

11 (8.46)

39 (6.11)

Comorbidity

    

 Fever

17 (13.82)

0 (0.00)

0 (0.00)

<  0.01

 Respiratory symptoms

25 (20.32)

24 (19.51)

118 (18.50)

0.88

 Gastrointestinal symptoms

9 (7.31)

7 (5.38)

37 (5.60)

0.76

 Syncope and dizzy

4 (3.25)

9 (6.92)

34 (5.33)

0.42

 Rash

1 (0.81)

1 (0.77)

3 (0.47)

0.85

Medical history

    

 Surgery

2 (1.63)

3 (2.30)

10 (1.57)

0.84

 Chronic disease

6 (4.88)

8 (6.15)

47 (7.37)

0.57

 Positive family history

8 (6.50)

7 (5.38)

36 (5.64)

0.92

 Drug allergy

3 (2.43)

1 (0.77)

13 (2.04)

0.57

  1. a Median visit time: the time from the latest onset to the visit